New studies suggest that Donanemab, an cutting-edge therapeutic , could lessen the advance of early-stage cognitive decline. This medication focuses on removing amyloid deposits within the brain , https://dirstop.com/story28250151/nadecenemab-an-potential-innovative-dementia-treatment